,,iv  #aag? ,,congress  #b;d ,session   
,h4 ,,res4 #ajfi  ,,9 ,,! ,,h\se ,,(    
,,repres5tatives  ,april #bh1 #bjbb,mr4 
,blum5au] 7= himself & ,mr4             
,fitzpatrick7 submitt$ ! foll[+         
resolution2 :i* 0 ref]r$ to ! ,committee
 on ,en]gy & ,comm]ce  ,,resolution     
,express+ support = ! designation ( ,may
 #g ea* ye> z ,bra9 ,donation ,aw>5ess  
,day4  ,:]eas #ajj1jjj1jjj ,am]icans are
 curr5tly liv+ ) disabl+ & debilitat+   
bra9 disord]s2 ,:]eas an additional     
#a1bjj1jjj p ag$ #ah ye>s & old] are    
diagnos$ annually ) adult onset bra9    
disease or disord]s 9 ! ,unit$ ,/ates2  
,:]eas bra9 disease has a trem5d\s      
impact on individuals1 families1 &      
society2 ,:]eas !re is a critical ne$ to
 improve ! und]/&+ ( :at causes         
neurological diseases1 includ+          
neurodeg5]ative1 neurodevelopm5tal1 &   
psy*iatric disord]s1 to develop new     
approa*es = prev5tion & treatm5t2 ,:]eas
 neurological conditions impact         
,am]icans ( all ages1 b ! risk (        

neurodeg5]ative diseases increases      
dramatically ) age2 ,:]eas ,am]icans are
 liv+ long] ?an ev]2 !re=e1 m p w be    
affect$ by neurodeg5]ative diseases 9   
com+ decades2 ,:]eas1 9 #bjba1          
#f1bjj1jjj ,am]icans 7 e/imat$ to be    
liv+ ) ,alzheim]'s disease2 ,:]eas an   
e/imat$ #a1bjj1jjj p 9 ! ,unit$ ,/ates  
c\ld be liv+ ) ,p>k9son's disease by    
#bjcj2 ,:]eas ab\t #a 9 #f *ildr5 9 !   
,unit$ ,/ates has #a or m developm5tal  
disabilities or o!r developm5tal delays2
 ,:]eas s]i\s m5tal illness is ris+1 )  
ov] #dg1jjj1jjj ,am]icans exp]i5c+ a    
m5tal illness 9 #bjba2 ,:]eas           
#gc1hjj1jjj adults ag$ #ah or old] 9 !  
,unit$ ,/ates report$ hav+ a m5tal heal?
 or sub/ance abuse disord] 9 #bjbj2     
,:]eas ! und]ly+ causes ( mo/           
neurological conditions rema9 l>gely    
unkn[n due to ! va/ complexity ( ! human
 bra92 ,:]eas ?r\gh rese>*1 ! und]ly+   
causes ( a great] numb] ( neurological  
conditions c be und]/ood2 ,:]eas ! ,food
 & ,drug ,adm9i/ration 7,,fda7 & !      

,national ,in/itutes ( ,heal? 7,,nih7   
support rese>* on new ways to treat1    
cure1 & prev5t neurological conditions2 
,:]eas ! ,director ( ! ,c5t] = ,drug    
,evaluation & ,rese>* ( ! ,,fda te/ifi$ 
be=e ,congress 9 #bjba t ! field (      
neurosci5ce requires m rese>* to develop
 new1 safe1 & effective treatm5ts2      
,:]eas ! ,,nih & in/itutes )9 ! ,,nih   
laun*$ ! ,bra9 ,rese>* ,?r\gh ,advanc+  
,innovative ,neurote*nologies 7,,bra97  
,initiative 9 #bjac & cont9ue to p>tn] )
 a numb] ( ,f$]al ag5cies & private     
sector p>tn]s on ! ,,bra9 ,initiative2  
,:]eas ! ,,nih-fund$ ,neuro,bio,bank 0  
e/abli%$ 9 ,septemb] #bjac z a national 
res\rce = inve/igators utiliz+ human po/
 mortem bra9 tissue & relat$ biospecim5s
 = _! rese>* to und]/& conditions ( !   
n]v\s sy/em2 ,:]eas po/ mortem bra9     
tissue is an irreplaceable res\rce 9    
bra9 rese>*2 ,:]eas !re is a critical   
ne$ to increase ! availability ( human  
diseas$ & control bra9s & relat$        
biospecim5s2 ,:]eas #a bra9 c provide   

tissue = doz5s1 ev5 hundr$s1 (          
neurological /udies2 ,:]eas communities 
( color & pov]ty are und]repres5t$ &    
und]/udi$ 9 neurological rese>*2 ,:]eas 
racial & socioeconomic div]sity is      
p>am\nt among bra9 donors s t rese>* c  
inve/igate h[ & :y neurological diseases
 & disord]s disproportionately affect   
m9ority & l[-income communities2 ,:]eas 
?r\gh aw>5ess1 ! public c be educat$ on 
h[ bra9 donation = neurosci5ce rese>* is
 n a r\t9e "p ( organ donation or       
anatomical body donation2 ,:]eas ! ,bra9
 ,donor ,project & ! ,am]ican ,bra9     
,coalition sponsor ,bra9 ,donation      
,aw>5ess ,day 9 ! ,unit$ ,/ates & p>tn] 
) _m o!r organizations to increase      
public aw>5ess ( neurological conditions
 & ! importance ( bra9 rese>*2 & ,:]eas 
,bra9 ,donation ,aw>5ess ,day is expect$
 to be obs]v$ 9 ! ,unit$ ,/ates = ye>s  
to come1 provid+ hope & in=mation =     
pati5ts1 c>egiv]s1 & families ar\nd !   
c\ntry3 ,n[1 !re=e1 be x ,t ! ,h\se (   
,repres5tatives--  7#a7 supports !      

designation ( ,bra9 ,donation ,aw>5ess  
,day2 &  7#b7 recognizes ! importance (1
 ) respect to neurological conditions & 
disord]s--  7,a7 improv+ aw>5ess2  7,b7 
rese>*2  7,c7 support+ national ef=ts to
 develop effective treatm5ts1           
diagno/ics1 & cures2  7,d7 support+     
national ef=ts to address ! urg5t ne$ = 
po/ mortem bra9 tissue1 bo? control &   
diseas$2 &  7,e7 educat+ on ! importance
 ( bra9 donation to support national    
rese>* ef=ts4